MXPA02005045A - Preparaciones farmaceuticas que contiene agentes citostaticos y aceptores de electrones para el tratamiento de cancer. - Google Patents

Preparaciones farmaceuticas que contiene agentes citostaticos y aceptores de electrones para el tratamiento de cancer.

Info

Publication number
MXPA02005045A
MXPA02005045A MXPA02005045A MXPA02005045A MXPA02005045A MX PA02005045 A MXPA02005045 A MX PA02005045A MX PA02005045 A MXPA02005045 A MX PA02005045A MX PA02005045 A MXPA02005045 A MX PA02005045A MX PA02005045 A MXPA02005045 A MX PA02005045A
Authority
MX
Mexico
Prior art keywords
pharmaceutical preparation
treating cancer
preparation containing
cytostatic agents
electron acceptors
Prior art date
Application number
MXPA02005045A
Other languages
English (en)
Inventor
Miklos Ghyczy
Original Assignee
Rhone Poulenc Rorer Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Gmbh filed Critical Rhone Poulenc Rorer Gmbh
Publication of MXPA02005045A publication Critical patent/MXPA02005045A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MXPA02005045A 1999-12-09 2000-11-25 Preparaciones farmaceuticas que contiene agentes citostaticos y aceptores de electrones para el tratamiento de cancer. MXPA02005045A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19959546A DE19959546A1 (de) 1999-12-09 1999-12-09 Pharmazeutische Zubereitung zur Behandlung von Tumorerkrankungen
PCT/EP2000/011761 WO2001041747A2 (de) 1999-12-09 2000-11-25 Pharmazeutische zubeteitung enthaltend zytostatika und electronenakzeptoren zur behandlung von krebs

Publications (1)

Publication Number Publication Date
MXPA02005045A true MXPA02005045A (es) 2003-09-25

Family

ID=7932121

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02005045A MXPA02005045A (es) 1999-12-09 2000-11-25 Preparaciones farmaceuticas que contiene agentes citostaticos y aceptores de electrones para el tratamiento de cancer.

Country Status (15)

Country Link
US (2) US20010021704A1 (es)
EP (1) EP1239862B3 (es)
JP (2) JP2003516348A (es)
AR (1) AR026911A1 (es)
AT (1) ATE299025T1 (es)
AU (1) AU781943B2 (es)
CA (1) CA2393487C (es)
DE (2) DE19959546A1 (es)
DK (1) DK1239862T3 (es)
ES (1) ES2243328T7 (es)
IL (2) IL149975A0 (es)
MX (1) MXPA02005045A (es)
PT (1) PT1239862E (es)
TW (1) TWI260224B (es)
WO (1) WO2001041747A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007009650A1 (de) * 2007-02-26 2008-08-28 Beiersdorf Ag Kosmetisches Kombinationsprodukt zur Verbesserung des äußeren Erscheinungsbildes
EP2544663B1 (en) 2010-03-12 2018-01-03 Berg LLC Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
EA201490047A1 (ru) 2011-06-17 2014-08-29 Берг Ллк Ингаляционные фармацевтические композиции
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
IL264950B2 (en) 2016-08-23 2024-01-01 Eisai R&D Man Co Ltd Combined treatments for the treatment of malignant liver cell carcinoma
WO2018094275A1 (en) 2016-11-18 2018-05-24 Tolero Pharmaceuticals, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
IL269357B1 (en) 2017-03-16 2024-06-01 Eisai R&D Man Co Ltd A combination of Era inhibitors and a CDK4/6 inhibitor to be used in a method to treat breast cancer
JP7196160B2 (ja) 2017-09-12 2022-12-26 スミトモ ファーマ オンコロジー， インコーポレイテッド Ｍｃｌ－１阻害剤アルボシジブを用いた、ｂｃｌ－２阻害剤に対して非感受性である癌の治療レジメン
EP3890749A4 (en) 2018-12-04 2022-08-03 Sumitomo Dainippon Pharma Oncology, Inc. CDK9 INHIBITORS AND POLYMORPHS THEREOF FOR USE AS CANCER TREATMENT AGENT
US11793802B2 (en) 2019-03-20 2023-10-24 Sumitomo Pharma Oncology, Inc. Treatment of acute myeloid leukemia (AML) with venetoclax failure
CN117417397A (zh) * 2023-10-17 2024-01-19 浙江亚瑟医药有限公司 一种盐酸伊达比星晶型及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0617309B2 (ja) * 1985-11-29 1994-03-09 株式会社ビタミン研究所 アドリアマイシン包埋リポソ−ム製剤
IN164232B (es) * 1986-04-11 1989-02-04 Hoechst India
DE3836676A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
DE19724796A1 (de) * 1997-06-06 1998-12-10 Max Delbrueck Centrum Mittel zur Antitumortherapie
PT1100589E (pt) * 1998-07-30 2005-05-31 Sigma Tau Ind Farmaceuti Utilizacao de propionil-l-carnitina e acetil-l-carnitina na preparacao de medicamentos com actividade anticancerigena
WO2000012071A2 (de) * 1998-08-29 2000-03-09 Miklos Ghyczy Pharmazeutisches und/oder diätetisches produkt
DE19843968A1 (de) * 1998-09-24 2000-04-13 Hans Dietl Taxane enthaltende pharmazeutische Zubereitung zur intravenösen Applikation und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
EP1239862B1 (de) 2005-07-06
ES2243328T7 (es) 2012-03-16
TWI260224B (en) 2006-08-21
WO2001041747A3 (de) 2002-02-07
DK1239862T3 (da) 2005-10-31
JP2012162577A (ja) 2012-08-30
US20040235783A1 (en) 2004-11-25
CA2393487C (en) 2010-11-09
JP2003516348A (ja) 2003-05-13
WO2001041747A2 (de) 2001-06-14
DE50010681D1 (de) 2005-08-11
CA2393487A1 (en) 2001-06-14
AR026911A1 (es) 2003-03-05
ES2243328T3 (es) 2005-12-01
AU781943B2 (en) 2005-06-23
PT1239862E (pt) 2005-10-31
EP1239862B3 (de) 2011-09-07
IL149975A (en) 2007-02-11
DE19959546A1 (de) 2001-06-21
IL149975A0 (en) 2002-12-01
US20010021704A1 (en) 2001-09-13
EP1239862A2 (de) 2002-09-18
ATE299025T1 (de) 2005-07-15
AU1704801A (en) 2001-06-18

Similar Documents

Publication Publication Date Title
EP1229934A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANCER BY MEANS OF IMMUNO-CONJUGATES AND CHEMOTHERAPEUTIC AGENTS
ZA200110022B (en) Thiazoloderivatives and pharmaceutical compositions containing them.
HK1045650A1 (en) Pharmaceutical composition.
HK1044290A1 (zh) X射線引導的藥物輸送
IL149224A0 (en) Hydrogen-driven drug dosage form
HK1022439A1 (en) Pharmaceutical compositions containing lactobacilli for treatment fo vaginal infections
ZA200000857B (en) Pharmaceutical composition.
MXPA02005045A (es) Preparaciones farmaceuticas que contiene agentes citostaticos y aceptores de electrones para el tratamiento de cancer.
IL152978A0 (en) Macromolecular drug complexes and compositions containing the same
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
HUP0100350A3 (en) Conjugates useful in the treatment of prostate cancer, pharmaceutical compositions comprising thereof, process for their preparation and their use
AUPQ232599A0 (en) Drug for treating fractures
ZA200203311B (en) Pharmaceutical carrier formulation.
HUP0201629A3 (en) Pharmaceutical complex containing eletriptan and cyclodextrin-derivative, pharmaceutical composition containing it, process for its preparation and its use
ZA200007111B (en) Methods and devices for providing prolonged drug therapy.
GB9917346D0 (en) Medicament for treating premature ejaculation
AU5706500A (en) Medicinal compositions for treating colorectal cancer
AU2001278738A1 (en) Medicinal compositions for preventing and treating cancer
HK1050533A1 (en) Substituted pyrroles as antiproliferative agents for the treatment of cancer.
ZA200203166B (en) Treatment of cancer.
ZA99168B (en) Pharmaceutical formulations and processes for their preparation.
HU9902296D0 (en) Pharmaceutical composition for treating caltification
AU4486500A (en) Therapeutic compositions and methods for treating tumors
AU4598100A (en) Treating cancer
ZA9811598B (en) A substance or composition for the treatment of cancer.

Legal Events

Date Code Title Description
FG Grant or registration